President Donald Trump’s administration has made an EXTREMELY controversial decision on experimental new vaccines which could prove to be just as deadly as the COVID-19 jab rollout…

The Trump admin has granted “Fast Track” designation to a brand new self-amplifying mRNA vaccine which is designed to combat the H5N1 avian influenza virus (Bird Flu.)

The vaccine, known as ARCT-2304, has been developed by Arcturus Therapeutics, and is now in Phase 1 trials.

Unlike traditional vaccines, ARCT-2304 uses a self-replicating mRNA platform, meaning the genetic material continues reproducing inside the recipient’s cells to boost production of flu-fighting proteins. Arcturus claims this results in a stronger immune response with smaller doses.

But in the past we have seen that self-replicating mRNA technologies can butcher the body’s immune system by inadvertently putting it into a state of constant fighting, contributing to bizarre new phenomena’s like rapidly progressing cancers nicknamed “turbo-cancers.”

The U.S. Food and Drug Administration (FDA) in partnership with the Department of Health and Human Services and its Biomedical Advanced Research and Development Authority (BARDA) are the agencies specifically behind the designation.

With all of the media hysteria and threats from the left-wing “experts” in the scientific community surrounding the potential for a bird flu pandemic to sweep across the United States, it’s not hard to see WHY the administration would think this was an appropriate response.

However, for those of us who remember how a similar designation for the COVID-19 vaccine led to the creation of one of the most deadly vaccines in human history – this is horrifying.

The Fast Track designation is designed to get new treatments in the hands of the public faster by effectively cutting red-tape at the FDA to expedite their approval.

But the issue with doing this for new vaccines is that it’s nearly impossible to predict the long-term side effects that they will produce in the human body once injected inside of them.

BARDA is the very same agency who was involved in Operation Warp Speed, back in 2020 which led to the accelerated development of the mRNA COVID-19 vaccines… and here they are again overseeing the development of ANOTHER new experimental mRNA vaccine.

What could possibly go wrong?

To make matters worse, the fast-track designation means that the American taxpayers will be footing bill for the Big Pharma giant who will likely make billions of dollars off of this injection…again, just like Operation Warp Speed.

“We are pleased to receive Fast Track Designation from the FDA for ARCT-2304,” said Joseph Payne, President and CEO of Arcturus Therapeutics.

“We remain steadfast in our commitment to the U.S. government to develop safe and effective STARR® next-generation mRNA vaccines to protect U.S. citizens from future pandemic threats. This designation from the FDA is an important step forward in our mission to provide protective solutions for global health crises,” Payne continued.

On the bright side, unlike President Joe Biden’s time in office, the Trump administration likely won’t be FORCING people to take this experimental injection.

Let’s just hope that Trump and co. learned from the failures of Operation Warp Speed and they don’t repeat those same mistakes here…